Company profile: OmniComm
1.1 - Company Overview
Company description
- Provider of Electronic Data Capture and eClinical technologies for clinical trial organizations and the life sciences industry, including pharma, biotech, CROs, diagnostic and device firms, and academic medical centers. Offerings include TrialMaster EDC; CTMS Master; RTSM Master; eTMF Master; AnjuEPS eSource/site automation for Early Phase clinics; and TA Scan clinical intelligence for study planning.
Products and services
- CTMS Master: Architects a workflow-driven clinical trial management system that connects users and key trial details, enabling oversight with streamlined workflows and built-in trial tools to manage studies
- RTSM Master: Engineers a modular platform for subject randomization and trial supply management, employing configurable trial modules to address various trial needs and streamline supply activities
- TrialMaster: Delivers an enterprise-grade Electronic Data Capture system that collects, processes, and submits clinical trial data, architected for Phase I–IV clinical trials to standardize data handling
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to OmniComm
StudyKIK
HQ: United States
Website
- Description: Provider of patient recruitment and retention technology for clinical trials, connecting trial companies with volunteers and offering KIKsite for data management and communication, Virtual Visits, CarePackage integrating telemedicine and eConsent, PatientEngage+ for enrollment and engagement, and SupportHub for outreach, appointment reminders, and transportation coordination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full StudyKIK company profile →
GRO Biosciences
HQ: United States
Website
- Description: Provider of protein therapeutics technology leveraging Genomically Recoded Organisms to produce non-standard amino acid proteins. Offers the GRO Platform to expand the amino acid alphabet; a Biofoundry integrating computational design and robotics; DuraLogic chemistry to enhance protein structure and duration; and ProGly to modulate immune responses, aiming to treat autoimmunity and reduce anti-drug antibodies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GRO Biosciences company profile →
Code Ocean
HQ: United States
Website
- Description: Provider of a computational research platform enabling reproducible, data-heavy science, offering Compute Capsules that bundle code, data, and environments for traceability; cloud Pipelines for building and deploying scalable workflows with automated environment and compute management; and a Lineage Graph tracking provenance, integrating with Git and supporting role-based access control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Code Ocean company profile →
ClinPlus
HQ: United States
Website
- Description: Provider of a suite of flexible clinical trial solutions designed to expedite studies, allowing sponsors to define unique standards and enabling CROs to meet varying demands across multiple study sponsors while satisfying strict FDA requirements, with capabilities spanning data collection and coding.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClinPlus company profile →
Aperio
HQ: United States
Website
- Description: Provider of digital pathology solutions for hospitals, reference labs, and pharmaceutical and research institutions across the world, offering an affordable, complete portfolio that enhances quality assurance, delivers more efficient workflows, and improves patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aperio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for OmniComm
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to OmniComm
2.2 - Growth funds investing in similar companies to OmniComm
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for OmniComm
4.2 - Public trading comparable groups for OmniComm
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →